Related Experiment Video
Updated: Sep 3, 2026

Obtaining Highly Purified Toxoplasma gondii Oocysts by a Discontinuous Cesium Chloride Gradient
Published on: November 3, 2009
BACE1: Now We Can See You
Salvatore Bongarzone1, Antony D Gee1
1School of Biomedical Engineering & Imaging Sciences, 4th Floor Lambeth Wing , St Thomas' Hospital, King's College London , London SE1 7EH , United Kingdom.
Abstract:
No in vivo imaging biomarker currently exists for BACE, a drug target for Alzheimer's disease (AD). A strategy aiming to find a novel brain-penetrant positron emission tomography (PET) radiotracer for BACE1 led to the discovery of a highly potent and selective aminothiazine inhibitor, PF-06684511. This scaffold has been now evaluated as BACE1 PET radiotracer ([18F]PF-06684511) after labeling with fluorine-18 (18F), allowing its evaluation in non-human primates (NHP) as the first a brain-penetrant PET radiotracer for imaging BACE1 in vivo.
Related Concept Videos
Interphase
Precipitation Reactions
Acids, Bases and Neutralization Reactions
Le Chatelier's Principle: Changing Concentration
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Interphase
Phases of Interphase
Following each period of mitosis and cytokinesis, eukaryotic cells enter interphase, during which they grow and replicate...

